Skip to content
Spa Intelligence

Try a real question: “Who can inject Botox in Montana?” or “Is $12 per unit the full price?” The index loads on first use; what you type is matched in this browser.

What changed

What changed, and when.

Two records. First, what changed at the source: dated FDA records about products and devices on spa menus. Then what changed on this site. Neither ranks a product or a clinic.

At the source

Approvals and clearances, safety communications, enforcement and recalls from FDA, newest first. Each keeps what the record establishes apart from what it doesn’t; a manufacturer’s announcement is linked as that, never as the record.

  1. Approval or clearance ·

    FDA cleared Ultherapy for the appearance of skin laxity on the knees

    U.S. Food & Drug Administration · 510(k) K260618

    510(k) K260618, "Ulthera System Expanded Indications (Knees)", decided May 21, 2026, adds the knees to the cleared indications. Merz announced it on August 11, 2026.

    What this source establishes
    That the cleared indications for this device now include the knees.
    What it does not establish
    Individual results, whether it suits a given person, or which operator credential a state requires.

    Relates to Ultherapy (Ulthera System)

    The official record (opens in a new tab) · Merz Aesthetics’s announcement (opens in a new tab) (the maker’s words, not the record) · checked Sep 25, 2026

  2. Enforcement or recall ·

    FDA warning letter to a Texas med spa over Botox from unauthorized sources

    U.S. Food & Drug Administration · FDA warning letter 723267

    A CDER warning letter dated April 1, 2026 said a med spa obtained botulinum toxin from entities that were not authorized trading partners and claimed it was authentic AbbVie Botox; FDA's laboratory analysis found botulinum neurotoxin type A in an unlabeled vial at the facility.

    What this source establishes
    That FDA found one named med spa sourced toxin outside the authorized supply chain while presenting it as Botox.
    What it does not establish
    Anything about any other clinic. It is why "where was this vial bought?" is a fair question to ask.

    Relates to Botox Cosmetic

    The official record (opens in a new tab) · checked Sep 25, 2026

  3. Approval or clearance ·

    FDA approved Radiesse, diluted 1:2 with saline, for décolleté wrinkles

    U.S. Food & Drug Administration · PMA P050052/S162

    A PMA supplement approved on March 31, 2026 expanded Radiesse's indications to subdermal implantation of Radiesse diluted 1:2 with 0.9% sterile saline for correcting décolleté wrinkles in patients 22 and older. Merz announced it on April 8, 2026.

    What this source establishes
    That Radiesse diluted 1:2 with saline, placed in the décolleté for adults 22 and older, is within the approved labeling.
    What it does not establish
    That undiluted Radiesse, another dilution or another area is approved for the décolleté, or who a state allows to inject it.

    Relates to Radiesse

    The official record (opens in a new tab) · Merz Aesthetics’s announcement (opens in a new tab) (the maker’s words, not the record) · checked Sep 25, 2026

  4. Enforcement or recall ·

    FDA warning letter to a stem cell clinic that also marketed exosomes

    U.S. Food & Drug Administration · FDA warning letter 712579

    A CBER warning letter dated February 11, 2026 addressed an umbilical cord-derived stem cell product marketed without approval. The same letter noted that the company's website also marketed exosomes.

    What this source establishes
    That FDA treated this company's products, as marketed, as unapproved biological products.
    What it does not establish
    Anything about the specific exosome product a spa uses; the letter concerns one company's products and claims.

    Relates to Exosome products (category)

    The official record (opens in a new tab) · checked Sep 25, 2026

  5. Enforcement or recall ·

    FDA warned 18 websites selling unapproved botulinum toxin

    U.S. Food & Drug Administration · FDA news release, 2025-11-05

    FDA issued 18 warning letters to owners of websites illegally marketing unapproved and misbranded botulinum toxin products, and restated that FDA-approved botulinum toxin products are available only with a prescription and should come from an authorized source.

    What this source establishes
    That FDA acted against specific websites selling unapproved or misbranded botulinum toxin, and that approved products are prescription-only.
    What it does not establish
    Whether a particular clinic's vial is genuine or where it was bought. The carton, the vial and the practice's supplier are what speak to that.

    Relates to Botox Cosmetic, Dysport, Xeomin, Jeuveau, Daxxify, Letybo

    The official record (opens in a new tab) · checked Sep 25, 2026

  6. Safety communication ·

    FDA safety communication on certain uses of RF microneedling

    U.S. Food & Drug Administration · FDA safety communication, 2025-10-15

    FDA reported serious complications with certain uses of radiofrequency microneedling, including burns, scarring, fat loss, disfigurement and nerve damage, described RF microneedling as a medical procedure rather than a cosmetic treatment, and pointed readers to the exact device's FDA record.

    What this source establishes
    That FDA has received reports of serious complications with certain uses of RF microneedling and considers it a medical procedure.
    What it does not establish
    That any particular device or clinic is unsafe, or anything about an individual reader's risk.

    Relates to Morpheus8, Secret RF, Vivace RF microneedling, Potenza RF microneedling

    The official record (opens in a new tab) · checked Sep 25, 2026

  7. Approval or clearance ·

    FDA cleared Ultherapy PRIME for skin laxity on the abdomen and arms

    U.S. Food & Drug Administration · 510(k) K243035

    510(k) K243035 (Ulthera, Inc., UC-1 Control Unit PRIME), decided February 24, 2025, covers improving the appearance of skin laxity on the abdomen, anterior arms and posterior arms. Merz announced the new indications on November 5, 2025.

    What this source establishes
    That the cleared indications for this device include the abdomen and the front and back of the arms.
    What it does not establish
    Individual results, whether it suits a given person, or which operator credential a state requires.

    Relates to Ultherapy (Ulthera System)

    The official record (opens in a new tab) · Merz Aesthetics’s announcement (opens in a new tab) (the maker’s words, not the record) · checked Sep 25, 2026

  8. Safety communication ·

    FDA alert: counterfeit Botox found in multiple states

    U.S. Food & Drug Administration · FDA drug alert, 2024-04-16 (updated 2024-05-01)

    FDA reported counterfeit Botox given to consumers, with hospitalizations. FDA's markers of the counterfeit: lot number C3709C3, the active ingredient printed as "Botulinum Toxin Type A" instead of "OnabotulinumtoxinA", a 150-unit vial, and non-English text on the carton. Updated May 1, 2024 with images of the authentic cartons.

    What this source establishes
    What FDA says the counterfeit and the authentic cartons and vials show, and that FDA advises confirming the product came from an authorized source.
    What it does not establish
    That a vial without those markers is genuine. Only an authorized supply chain establishes that, and a photograph cannot.

    Relates to Botox Cosmetic

    The official record (opens in a new tab) · checked Sep 25, 2026

  9. Enforcement or recall ·

    Recall of five CoolSculpting applicator models, still open in FDA's database

    U.S. Food & Drug Administration · FDA recalls Z-1346-2022 to Z-1350-2022 (event 90331)

    On June 9, 2022 Zeltiq Aesthetics began removing its parallel plate applicators (CoolCore, CoolCurve, CoolCurve+, CoolMax and CoolFit, cleared under K181740) because of an increased rate of complaints of paradoxical hyperplasia during 2019–2021. FDA classified it as a Class 2 device recall; its record still read "Open, Classified" when checked, meaning not all products had been corrected or removed.

    What this source establishes
    That these five applicator models were recalled for an increased complaint rate of paradoxical hyperplasia, and the recall's FDA class and status.
    What it does not establish
    Whether the applicator a clinic uses is one of these models, or anything about the CoolSculpting Elite system's own clearance. Ask which applicator will be used.

    Relates to CoolSculpting Elite

    The official record (opens in a new tab) · checked Sep 25, 2026

On this site

When a source is rechecked or a rule changes, the page it’s on shows the new date.

  1. — Official records, one place on one page, and a packet you can print

    The tools now connect: what a place told you, what an official record shows, what you checked yourself and what is still unknown sit side by side and stay apart. Nothing here scores a place or tells you what to book.

    • Type a number from the box on /identify — an NDC, a device identifier or full UDI, a 510(k), PMA or application number — and look it up in FDA’s own records, with any recall filed under it. Nothing is sent until you press the button, and the button says exactly what goes.
    • A match says an official record exists for that number. It never says the vial or device in front of you is that product, and “no recall returned” is never “never recalled”.
    • Compare a Botox carton with FDA’s counterfeit notice, word for word: the lot, the ingredient wording, the unit sizes, the maker’s name and the carton language. It runs in this browser, and it can find a sign FDA listed — it can’t show a vial is genuine.
    • Product pages list the FDA recalls filed under that product’s number, with the lots or models each one covers.
    • The Decision Workspace at /workspace puts one place’s whole file on one page and lists what to ask next — each with the reason it’s there.
    • The Decision Record is now a packet: what the place said, what an official source establishes, what you recorded and what remains unknown, kept apart; what to ask next; and the money in five lines. It prints cleanly.
    • Money in five lines wherever a place is summed up: what it takes to book or start, the first twelve months, each year after, prepaid money at risk at the expiry, and what a financing offer needs you to pay to clear it in time.
    • You can add a quote from your file to the anonymous price ranges, prefilled and with every field shown. The place’s name is never part of it.
    • A combined menu line — “RF microneedling + PRP with an exosome finish” — is read as the parts it combines, each with its own product, person and record to ask about.
    • State pages say which topics we found official statements on, which we didn’t, and the exact question to put to the board. Michigan, New Jersey and five thinner states gained rules.
    • Search covers state rules, products by FDA number, makers, claims, credentials, money, regulator records and learning paths — and says why each result matched. It still runs in this browser.
    • The site works offline for pages you’ve opened and your booking file, and says so when you’re offline.
    • Page headings show immediately instead of fading in after the page loads, and text on phones no longer runs to the screen edge.
  2. — Pages that say what they are before your file loads

    The tool pages used to show a blank frame while your booking file was read out of this browser. They now say what they are first.

    • The before-you-book check and the 2 a.m. test show their heading and what they’re for straight away, then fill in your saved places once the file has loaded.
    • The home page does the same: the useful part is there before anything is read out of storage.
  3. — Learning paths, treatments side by side, and search

    A way to work through this from the beginning, a way to hold two treatments up against each other, and a search box on every page. Nothing here ranks a provider or tells you what to book.

    • Learning paths at /learn: three of them — Start here, Go deeper, and Check it yourself. Each is an ordered set of steps through pages that already exist, with a line on why each one matters before you book.
    • Every path ends in practice: real-looking ads and offers to read yourself, marked the same way the tools mark a real one.
    • Your place in a path is ticked off and kept in this browser with the rest of your file. There’s still no account.
    • Paths and your own file together suggest the few things most worth doing next, rather than a list of everything.
    • Compare treatments at /compare-treatments: two or more held side by side on what they’re for, the tradeoffs, downtime, maintenance and the alternatives. No rankings and no verdict.
    • Treatment pages gained a before-you-book checklist you can print and take with you.
    • Treatment pages now separate what a treatment costs to start, what it costs in the first twelve months, and what a normal maintenance year costs — so a package can’t make upkeep disappear.
    • After a consult, you can record what changed and what you were told, against a snapshot of your file from before you went in.
    • A search box in the header on every page, covering the whole site. It runs in this browser; what you type isn’t sent anywhere.
    • A short guided introduction the first time you arrive, and a bar linking the other Vanity or Vice tools.
    • Light and dark appearance controls on every page, not just one.
    • The site was redesigned: new palette, new type, and a home page that reads as a page rather than a wall of panels.
    • Fixes to text contrast, mobile layout, and the charts on the quote and financing pages.
  4. — Spa Intelligence rebuilt

    The site was rebuilt from the ground up. The rules didn’t change: education only, no rankings, and anything unanswered stays marked as unanswered.

    • A before-you-book check: thirteen questions, each marked Answered, Half-answered, Not answered yet or Declined.
    • A booking file that lives in this browser, with export. There’s no account to create.
    • If you used the previous version, what it saved in this browser is carried across the first time you visit.
    • A document reader for quotes, DMs, menus, consent forms and reviews, with the exact wording behind every item.
    • Treatment guides: what the menu name leaves out, how it’s priced, and the three questions to ask first.
    • State pages for all 50 states and DC with license lookups and plain summaries of official sources, each with its source and the date we checked.
    • A credential check that points to the right state board for the license someone claims.
    • A product and device registry, and an identity check: what FDA records show a product is authorized for, and how to check it’s the real thing.
    • A marketing claims library, with a paste box that reads an ad in your browser.
    • A credentials dictionary, including titles that sound like licenses and aren’t.
    • Eight guides, from reading a consent form to what to do if something goes wrong.
    • Money explainers, a quote calculator, and a financing and prepay calculator.
    • The 2 a.m. test, consult prep with an in-room mode, side-by-side comparison, and a printable Decision Record with share links.